Advancing Triple-Negative Breast Cancer Research in the Asia-Pacific Region
The genetic diversity in the Asia-Pacific region is crucial for personalized treatment approaches and the development of novel biomarkers, addressing the urgent clinical need for innovative treatments in regions with limited access to standard care for …